Skip To Content

Study ID: COG AALL08B1


Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

The purpose of this study is to provide a risk classification scheme for all patients with newly diagnosed ALL, which will be used to assign treatment on Children¿s Oncology Group (COG) frontline ALL treatment studies and to capture classification data for correlative studies accompanying current COG ALL treatment protocols. Participants in this study have been diagnosed with Acute Leukemia that might be Acute Lymphoblastic Leukemia (ALL). Acute Leukemia is a cancer of the blood and bone marrow. The additional purposes of this study aim to provide a central reference guide for all required and research studies that will be conducted in local and reference laboratories for all newly diagnosed patients with ALL and to provide a mechanism for optional banking of leukemia and germline specimens for current and future research.
Fargo Region, Sioux Falls Region
Principal Investigator:
Kayelyn Wagner, MD,Samuel Anim, MD
ALL (Acute Lymphocytic Leukemia)
Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.